Ten-Year Medicare Use and Spending on the 10 Drugs Selected for Negotiation Under the Inflation Reduction Act

被引：0

作者：

Essa, Mohammed ^{[1
,2
]}

Ross, Joseph S. ^{[3
,4
]}

Dhruva, Sanket S. ^{[5
]}

Desai, Nihar R. ^{[4
,6
]}

Spatz, Erica S. ^{[4
,6
]}

Faridi, Kamil F. ^{[4
,6
]}

机构：

[1] Catholic Med Ctr, New England Heart & Vasc Inst, Manchester, NH USA

[2] Harvard TH Chan Sch Publ Hlth, Boston, MA USA

[3] Yale Sch Publ Hlth, Yale Sch Med, Dept Hlth Policy & Management, Sect Gen Internal Med,Dept Med, New Haven, CT USA

[4] Yale New Haven Hlth Syst, Ctr Outcomes Res & Evaluat, New Haven, CT USA

[5] Univ Calif San Francisco, Sch Med, Dept Med, Sect Cardiol, San Francisco, CA USA

[6] Yale New Haven Hlth Syst, Yale Sch Med, Ctr Outcomes Res & Evaluat, Sect Cardiovasc Med,Dept Internal Med, New Haven, CT USA

来源：

JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2025年 / 14卷 / 03期

关键词：

cardiovascular diseases; drug costs; Medicaid; Medicare Part D; prescription drugs;

D O I：

10.1161/JAHA.124.034682

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 34 条

[11] INFLATION REDUCTION ACT (IRA) IMPACT: MEDICARE PART D BENEFICIARIES OUT-OF-POCKET SPENDING ON INSULIN
Varghese, I
Liu, Z.
Kardel, P.
Sheetz, C.
VALUE IN HEALTH, 2023, 26 (06) : S235 - S235
[12] The Inflation Reduction Act: Implications for Medicare spending and access to biologic therapies for chronic rhinosinusitis with nasal polyposis and asthma
Rathi, Vinay K.
Soler, Zachary M.
Schlosser, Rodney J.
Workman, Alan D.
Chapurin, Nikita
Rowan, Nicholas R.
Dusetzina, Stacie B.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2024, 14 (07) : 1261 - 1265
[13] Insulin Fills by Medicare Enrollees and Out-of-Pocket Caps Under the Inflation Reduction Act
Myerson, Rebecca
Qato, Dima M.
Goldman, Dana P.
Romley, John A.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (07): : 660 - 662
[14] Medicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016-2019 data
Qureshi, Omar
Ramachandran, Reshma
Ross, Joseph S.
JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2024, 17 (01)
[15] Out-of-Pocket Prescription Drug Savings for Medicare Beneficiaries with Asthma and COPD Under the Inflation Reduction Act
Mein, Stephen A.
Tale, Archana
Rice, Mary B.
Narasimmaraj, Prihatha R.
Wadhera, Rishi K.
JOURNAL OF GENERAL INTERNAL MEDICINE, 2024, : 1141 - 1149
[16] Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Risk Factors Under the Inflation Reduction Act
Narasimmaraj, Prihatha R.
Oseran, Andrew
Tale, Archana
Xu, Jiaman
Essien, Utibe R.
Kazi, Dhruv S.
Yeh, Robert W.
Wadhera, Rishi K.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (15) : 1491 - 1501
[17] Using a patient-centered value assessment to optimize fair prices for Inflation Reduction Act's Medicare Drug Price Negotiation Program
Poudel, Nabin
Ngorsuraches, Surachat
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (03): : 241 - 246
[18] Out-of-Pocket Prescription Drug Savings for Medicare Beneficiaries With Obstructive Lung Disease Under the Inflation Reduction Act
Mein, S.
Tale, A.
Rice, M. B.
Wadhera, R. K.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
[19] Value-Based Pricing and Its Implications for the Newly Announced Medicare Negotiated Price Under the Inflation Reduction Act
Li, Piaopiao
Ali, Mohammed K.
Narayan, K. M. Venkat
Umpierrez, Guillermo E.
Fonseca, Vivian A.
Shi, Lizheng
Shao, Hui
DIABETES CARE, 2025, 48 (04) : e44 - e46
[20] Changes in Out-of-Pocket Drug Expenditures Among Medicare Beneficiaries With Dementia Under the Inflation Reduction Act: A Simulation Study
Zhu, Yingying
Olchanski, Natalia
Freund, Karen M.
Cohen, Joshua T.
Neumann, Peter J.
Lin, Pei-Jung
VALUE IN HEALTH, 2025, 28 (04) : 553 - 561

← 1 2 3 4 →